Announced Wed, 24 Jun · 13:20 IST
Promoter Swapan Khandelwal buys 60,000 shares of Goldline Pharma
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹44.75
prior close
₹44.32
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+1.4-3.5-3.8-4.2-5.5-5.6-6.0-12.7-10.6——
Up moveDown movePending
AI summary
Promoter and Whole Time Director Swapan Khandelwal acquired 60,000 equity shares (0.62%) of Goldline Pharmaceutical through open market purchase on 22nd June 2026. His stake rose from 28.65% to 29.27%, taking total holding to 28,09,988 shares. No encumbrance, pledge, or off-market deal involved; purely an open market buy disclosed under SEBI SAST Regulation 29(2).
Likely market impact
Small promoter purchase signals confidence but size is modest; holding still well below 50% so no major control implication.